This inventor holds 3 USPTO granted patents, plus 3 CIPO patents. Top assignee: Synergia Medical. Active years: 2019-2025.
Company Filing History:
Years Active: 2019-2025
Title: Innovations by Gregory Thiebaut
Introduction
Gregory Thiebaut is a notable inventor based in Mont-Saint-Guibert, Belgium. He has made significant contributions to the field of medical technology, particularly in the development of devices that stimulate the vagus nerve. With a total of 3 patents to his name, Thiebaut's work is paving the way for advancements in therapeutic interventions.
Latest Patents
Thiebaut's latest patents include a control system for an implantable stimulating device designed to stimulate the vagus nerve. This innovative kit provides a method for delivering electric or electromagnetic pulses to the vagus nerve through an implanted device. Another significant patent involves a cuff electrode or optrode that is designed to encircle cylindrical tissue. This implantable device features a support sheet rolled about a longitudinal axis, forming a cuff with specific dimensions and thicknesses, ensuring effective stimulation while maintaining comfort for the patient.
Career Highlights
Gregory Thiebaut is currently associated with Synergia Medical, where he continues to develop groundbreaking medical technologies. His expertise in the field has led to the creation of devices that enhance patient care and treatment outcomes. His work is characterized by a commitment to innovation and a focus on improving the quality of life for individuals with medical conditions requiring nerve stimulation.
Collaborations
Thiebaut collaborates with talented professionals in his field, including Pascal Doguet and Marie Dautrebande. These partnerships foster a creative environment that encourages the exchange of ideas and the development of cutting-edge technologies.
Conclusion
Gregory Thiebaut's contributions to medical technology through his patents and collaborations highlight his role as an influential inventor. His work continues to inspire advancements in the field, ultimately benefiting patients in need of innovative therapeutic solutions.